StockNews.com Upgrades InfuSystem (NYSE:INFU) to Strong-Buy

StockNews.com upgraded shares of InfuSystem (NYSE:INFU) from a buy rating to a strong-buy rating in a research note published on Friday.

InfuSystem Trading Up 0.9 %

NYSE INFU opened at $6.46 on Friday. The company has a debt-to-equity ratio of 0.64, a current ratio of 2.07 and a quick ratio of 1.64. The company has a market cap of $137.57 million, a P/E ratio of -646,000.00 and a beta of 1.46. InfuSystem has a 52 week low of $5.74 and a 52 week high of $10.99.

InfuSystem (NYSE:INFU) last posted its quarterly earnings data on Thursday, August 8th. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.04 by ($0.01). The firm had revenue of $33.70 million for the quarter. InfuSystem had a return on equity of 0.70% and a net margin of 0.28%.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the stock. Squarepoint Ops LLC acquired a new position in InfuSystem during the 2nd quarter valued at approximately $230,000. Marshall Wace LLP acquired a new position in InfuSystem during the 2nd quarter valued at approximately $131,000. First Eagle Investment Management LLC increased its stake in shares of InfuSystem by 10.0% in the second quarter. First Eagle Investment Management LLC now owns 666,048 shares of the company’s stock worth $4,549,000 after acquiring an additional 60,813 shares during the period. Oppenheimer Asset Management Inc. increased its stake in shares of InfuSystem by 52.1% in the second quarter. Oppenheimer Asset Management Inc. now owns 26,042 shares of the company’s stock worth $178,000 after acquiring an additional 8,917 shares during the period. Finally, Perritt Capital Management Inc increased its stake in shares of InfuSystem by 169.4% in the second quarter. Perritt Capital Management Inc now owns 38,500 shares of the company’s stock worth $263,000 after acquiring an additional 24,207 shares during the period. Institutional investors and hedge funds own 71.13% of the company’s stock.

InfuSystem Company Profile

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.